Table 1.
Overview of treatment groups.
Fig 1.
PRISMA flowchart for searching and selecting eligible studies.
Fig 2.
Six out of 23 studies considered to have a high overall risk of bias.
Table 2.
Basic demographic data of RCT studies included in the review.
Fig 3.
A1. Geometry of the network for complete ablation of BE(NDBE). Each dot represents a treatment modality. Lines between dots shows a direct comparison, for example, a study comparing these two treatments. Thicker lines indicate more studies. A2. Geometry of the network for complete ablation of BE(LGD+HGD+EC). Each dot represents a treatment modality. Lines between dots shows a direct comparison, for example, a study comparing these two treatments. Thicker lines indicate more studies. B1. Forest plot for complete ablation of BE(NDBE). Argon plasma coagulation compared against the other treatments. Results are presented as difference in complete ablation of BE with 95% confidence intervals. B2. Forest plot for complete ablation of BE(LGD+HGD+EC). Argon plasma coagulation compared against the other treatments. Results are presented as difference in complete ablation of BE with 95% confidence intervals. C1. SUCRA plot for complete ablation of BE(NDBE). SUCRA, surface under the curve cumulative ranking probabilities, shows probability of ranking for each treatment illustrated by graphs. C2. SUCRA plot for complete ablation of BE(LGD+HGD+EC). SUCRA, surface under the curve cumulative ranking probabilities, shows probability of ranking for each treatment illustrated by graphs. D1. Comparative efficacy ranking league matrix (Complete ablation of BE(NDBE)). Comparison of all treatment in the network, combined indirect and direct if, available. Results are presented as difference in complete ablation of BE with 95% confidence intervals. Red color shows an advantage for treatment, blue color disadvantage. D2. Comparative efficacy ranking league matrix (Complete ablation of BE(LGD+HGD+EC)). Comparison of all treatment in the network, combined indirect and direct if, available. Results are presented as difference in complete ablation of BE with 95% confidence intervals. Red color shows an advantage for treatment, blue color disadvantage.
Fig 4.
A. Geometry of the network for neoplastic progression. Each dot represents a treatment modality. Lines between dots shows a direct comparison, for example, a study comparing these two treatments. Thicker lines indicate more studies. B. Forest plot for neoplastic progression. Argon plasma coagulation compared against the other treatments. Results are presented as difference in neoplastic progression with 95% confidence intervals. C. SUCRA plot for neoplastic progression. SUCRA, surface under the curve cumulative ranking probabilities, shows probability of ranking for each treatment illustrated by graphs. D. Comparative efficacy ranking league matrix (Neoplastic progression). Comparison of all treatment in the network, combined indirect and direct if, available. Results are presented as difference in neoplastic progression with 95% confidence intervals. Red color shows an advantage for treatment, blue color disadvantage.
Fig 5.
A. Geometry of the network for complete eradication of dysplasia. Each dot represents a treatment modality. Lines between dots shows a direct comparison, for example, a study comparing these two treatments. Thicker lines indicate more studies. B. Forest plot for complete eradication of dysplasia. Argon plasma coagulation compared against the other treatments. Results are presented as difference in complete eradication of dysplasia with 95% confidence intervals. C. SUCRA plot for complete eradication of dysplasia. SUCRA, surface under the curve cumulative ranking probabilities, shows probability of ranking for each treatment illustrated by graphs. D. Comparative efficacy ranking league matrix (Complete eradication of dysplasia). Comparison of all treatment in the network, combined indirect and direct if, available. Results are presented as difference in complete eradication of dysplasia with 95% confidence intervals. Red color shows an advantage for treatment, blue color disadvantage.